Powering Progress to Save Lives

Janie Ferling

Melanoma

When Janie, a mother from L.A., learned that a lump in her neck was malignant melanoma, she was determined to do whatever she could to be around as long as possible for her son.

Brenda Berchtold

Breast Cancer

When Brenda, 51, was first diagnosed with triple-negative breast cancer in 1986, her treatment options were limited. But much has changed since then, and Brenda is now receiving immunotherapy.

Judy Gray

Lung Cancer

When Judy, 68, was facing a diagnosis of stage 4 lung cancer, she took a predictably analytic approach to her treatment options and enrolled in a new immunotherapy clinical trial.

Emily Whitehead

Leukemia

At only 6-years-old, Emily faced a life-threatening recurrence of leukemia. Determined to save her life, her parents enrolled her in a clinical trial.

Marguerite Sullivan

Melanoma

Marguerite credits immunotherapy with allowing her to carry on with her normal life while also receiving the best care for her cancer, metastatic melanoma.

Brendan Connors

Melanoma

After successfully finishing a combination of immunotherapies for metastatic melanoma, 32-year-old Brendan seized any opportunity for adventure.

Don H.

Lung Cancer

When computer professional Don, 61, was facing a grim prognosis from chemo-resistant lung cancer, he did what came naturally: he took to Google to research his options and learned about immunotherapy.

Maureen O'Grady

Lung Cancer

In 2010, Maureen participated in a clinical trial of a new immunotherapy drug called nivolumab to treat her stage 4 lung cancer.

Bob Carlson

Lung Cancer

Because chemotherapy for his stage 4 lung cancer was a concern, Bob, 71, enrolled in an immunotherapy clinical trial.

Richard Catlett

Kidney Cancer

For 7 years, Richard endured round after round of treatment for kidney cancer, but it always came back. Then, in 2013, he enrolled in a clinical trial of nivolumab.

Lynn Luckeroth

Melanoma

Lynn is no stranger to cancer, having lost both her mother and her son to the disease. When she herself was diagnosed with melanoma, she looked to immunotherapy.

Gene Ogle

Pancreatic Cancer

When Gene learned he had pancreatic cancer, he was determined to spend more time with his grandchildren by enrolling in cancer immunotherapy clinical trials.

Sue Bohlin

Melanoma

Sue was free from breast cancer after a five-year battle, but she was diagnosed with a new, unrelated cancer two years later: melanoma.

John Yaryan

Prostate Cancer

When John, a 77-year-old Air Force veteran, was diagnosed with stage IV prostate cancer, he enrolled in a clinical trial to test the immunotherapy Yervoy.

Christine Sable

Ovarian Cancer

Ovarian cancer survivor Christine shares her powerful story of hope and perseverance in the face of "the cancer that whispers."

DJ Eric Prydz

The famous DJ donated ticket sales from his concerts to CRI in honor of super-fan James Lillo.

Inlanta Mortgage

Inlanta Mortgage again chose CRI to be the beneficiary at their yearly conference’s raffle.

Tiffany and Sage Berting

7-year-old Sage wanted to honor those who lost their lives to cancer. So she drew pictures to raise funds for cancer research.

TeeTurtle

Saddened by the actor Alan Rickman's death from pancreatic cancer, a T-shirt company raised $54,000 for CRI from a Harry Potter-themed T-shirt.

Jessica Haze

A popular makeup artist's goal to raise $100,000 in 100 days for CRI.

Tidewater Travel

Because Janet, a travel agent, lost family and friends to cancer, she wanted to create a cruise fundraiser to support a more effective type of cancer treatment for patients.

Nolan and Ileana Beck

In memory of his lifelong friend, Bryce, Nolan and his wife, Ileana, decided to bike across country to raise funds for immunotherapy research.

Sherri Thompson

Sherri doesn't know a single family that hasn't been touched by cancer. So when she learned of CRI's work, she wanted to do something big and held a benefit concert.

Enphase Energy

Inspired by her coworkers battling cancer, Deborah came up with an idea: she would shave her head if her company raised $5,000 for CRI.

James McGary

Professional longboarder James is going the distance: he's longboarding from Seattle to New York City to raise money for CRI.

Emma Saunders

With her family ravaged by cancer, Emma wanted to do something huge to help conquer the disease. She decided to run in the Great Wall of China Marathon as a fundraiser for CRI.

Jacques C. Nordeman

CRI trustee Jacques Nordeman has been steering the course against cancer for more than three decades.

David Courtenay

Having had four brothers battle cancer, David was inspired to make a 800km fundraising trek a journey of a lifetime.

Mary Jo Bramson

Mary Jo and her friends organized fundraisers over the next 10 years for CRI, raising more than $687,000 in total.

Joel Paula

Cyclist Joel Paula biked 4,000 miles to raise money for the Cancer Research Institute, and to prove he could do it.

Penny Bolton

Each year, Penny holds a fashion fundraiser for cancer research by selling bras for a cause.

Mark Fischbach

In February 2013, Mark Fischbach, also known as "Markiplier" on his popular YouTube channel, raised more than $8,000 for CRI in just 9 hours, by playing video games.

Keith Landesman, M.D.

Cardiologist Dr. Landesman tragically lost his life to cancer in 2008. To honor his memory, his family hosts their annual golf tournament and silent auction to support cancer research.

MacLean C. Sellars, Ph.D.

Former CRI postdoctoral fellow MacLean ran the 2012 Marine Corps Marathon in memory of his mother and helped raise $3,000 for CRI.

Alexis Feldman

Since 2008, Alexis Feldman has led a group of highly motivated young New York City professionals who are committed to ending cancer deaths.

James P. Allison, Ph.D.

The University of Texas at MD Anderson Cancer Center

CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.

Jeffrey Chou, M.D., Ph.D.

Fred Hutchinson Cancer Research Center

New studies from this CRI scientist may help to make colorectal cancer more vulnerable to attack by the immune system.

Ian H. Frazer, AC, FRS, FAA

The University of Queensland, Australia

The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.

Jing-Ping Hsin, Ph.D.

Memorial Sloan Kettering Cancer Center

The CRI Young Philanthropist Fellow's research on gene expression in cancer can impact the way lymphoma is treated.

Carl H. June, M.D.

University of Pennsylvania

Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.

Hyam I. Levitsky, M.D.

Johns Hopkins University

Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.

Haihui Lu, Ph.D.

Whitehead Institute for Biomedical Research

As a postdoctoral fellow funded by CRI, Dr. Lu is forging new knowledge on how breast cancer tumors "hijack" macrophages to facilitate cancer metastasis and immune evasion.

Kunle Odunsi, M.D., Ph.D.

Roswell Park Cancer Institute

CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.

Oliver M. Pearce, Ph.D.

University of California, San Diego

A CRI postdoctoral fellow is researching the link between red meat, milk, and carcinomas.

Corrie Painter, Ph.D.

University of Massachusetts

Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.

David A. Reardon, M.D.

Dana-Farber Cancer Institute

For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.

Antoni Ribas, M.D., Ph.D.

University of California, Los Angeles

Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.

Padmanee Sharma, M.D., Ph.D.

The University of Texas at MD Anderson Cancer Center

Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.

Ralph Steinman, M.D.

The Rockefeller University

Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.

Jedd D. Wolchok, M.D., Ph.D.

Memorial Sloan Kettering Cancer Center

The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.

Matthew Youngman, Ph.D.

Massachusetts Institute of Technology

A CRI postdoctoral fellow is exploring the link between aging and the immune system, and his work could lead to new immunotherapies that boost protection against cancer.